The shadow of generic competition has repeatedly loomed around copyright’s iconic drug, Sildenafil, raising questions about the future of related click here drug ventures. While initial periods saw impressive returns, the patent end has opened the path for cheaper substitutes, potentially lowering revenue and presenting a real hazard for stakehol